Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nerviheal (methylcobalamin + nicotinamide + pyridoxine) is an injectable multivitamin combination developed by Heal All Pharmaceuticals for the treatment of diabetic peripheral neuropathy, drug-induced neuropathy, alcoholic neuropathy, and burning hands and feet syndrome. It contains methylcobalamin (an active form of vitamin B12 that supports neuronal repair and myelin sheath regeneration), nicotinamide (vitamin B3, which enhances energy metabolism and vascular supply to nerves), and pyridoxine (vitamin B6, which aids in neurotransmitter synthesis and nerve impulse transmission). The combination is approved and marketed in India as an injection for intramuscular or intravenous administration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on methylcobalamin + nicotinamide + pyridoxine (Heal All Pharmaceuticals).